Anchen Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2004-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://anchen.com
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 3:2
Drug Approvals
1
FDA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (100.0%)Evaluation of Clinical Endpoints of Two Diclofenac Sodium Gel 1%
- First Posted Date
- 2011-10-21
- Last Posted Date
- 2012-07-12
- Lead Sponsor
- Anchen Pharmaceuticals, Inc
- Target Recruit Count
- 749
- Registration Number
- NCT01456611
- Locations
- 🇺🇸
Novum Investigator Site, Newport News, Virginia, United States
Evaluation of Clinical Equivalence Between Two Lubiprostone Products
Phase 3
Completed
- Conditions
- Chronic Idiopathic Constipation
- Interventions
- Drug: Placebo
- First Posted Date
- 2011-06-14
- Last Posted Date
- 2012-07-12
- Lead Sponsor
- Anchen Pharmaceuticals, Inc
- Target Recruit Count
- 808
- Registration Number
- NCT01372423
- Locations
- 🇺🇸
Novum Investigator Site, Mountain Lake, Washington, United States
🇺🇸Novum Invesitgator Site, Hollywood, Maryland, United States
News
No news found